Headlines

• Tennessee Legislature Passes FAIR Rx Act

  • Tuesday, April 28, 2026

  Last week, the Tennessee General Assembly has taken major action on the Freedom, Access and Integrity in Registered Pharmacy (FAIR Rx) Act (SB 2040/HB 1959). The bill passed with strong support, 24-9 in the Senate and 86-7 in the House, and now advances to the Governor's desk for signature. If enacted, the FAIR Rx Act would prohibit PBMs from owning or operating pharmacies in Tennessee. This approach targets one of the most pressing issues facing pharmacists today: conflicts of interest that can drive up drug costs, limit patient choice, and steer patients toward PBM-affiliated pharmacies, often at the expense of independent and community-based providers. This progress for our neighbors to the south was achieved despite significant opposition, emphasizing the importance of grassroots advocacy and the growing recognition among policymakers that the PBM reform fight is far from over, and that further action is needed to ensure a fair and transparent pharmacy marketplace. For Kentucky pharmacists, this development reinforces the importance of continued engagement and advocacy here at home and at the federal level. Efforts like the FAIR Rx Act closely align with ongoing conversations around PBM reform and patient access that KPhA continues to actively monitor and address on your behalf in both Frankfort and Washington, D.C.

  Read More

• KPhA MEMBER OPPORTUNITY: Two Complimentary CEU Now Available

  • Wednesday, April 22, 2026

  1.)  Beyond Withdrawal: Inpatient Management of Opioid Use Disorder (0.1 CEU) This continuing education session will examine medications used to treat opioid use disorder (MOUD), including buprenorphine (with or without naloxone), methadone, and naltrexone, and will highlight the critical opportunity hospitalization presents for initiating therapy.  2.) Beyond Beta-Blockers: The Pathophysiology & Pharmacotherapy of Hypertrophic Obstructive Cardiomyopathy (0.1 CEU) In this session, participants will review the pathophysiology and classification of obstructive and nonobstructive HCM, examine the 2024 AHA/ACC guideline recommendations for management including first-line therapy, and the role of cardiac myosin inhibitors with a focus on mavacamten.  These complimentary opportunities are offered exclusively to KPhA members in partnership with Baptist Health. As a valued member benefit, we kindly ask that you reach out to Danielle Gross, KPhA Education Coordinator, to access these free CE classes.  Her email is dgoss@kphanet.org. 

  Read More

• In Memoriam: Alan C. Simon

  • Wednesday, April 22, 2026

  It is with deep sorrow that we announce the passing of Alan C. Simon, a cherished member of the Kentucky Pharmacists Association (KPhA), who left us on April 7, 2026, at the age of 79. Alan was a beloved figure in our community, known for his unwavering commitment to service and his compassionate approach to pharmacy. He dedicated his professional life to providing integrative and holistic care at Simon's Prospect Apothecary, where he touched countless lives with his expertise and kindness. Alan's service extended beyond the pharmacy as he proudly served in the U.S. Army and later took on a role in local government, elected to the Prospect City Council. His leadership was recognized through numerous accolades, including serving as President of the North Oldham Lions Club (1984–1985) and receiving the Melvin Jones Fellowship for his humanitarian efforts. He was honored as Pharmacist of the Year by Ciba-Geigy Pharmaceuticals in 1993 and was the recipient of the Craigmyle Award from the City of Prospect in 1997 for his dedicated community service. Alan's legacy of compassion and integrity will continue to inspire all who knew him. To read his full obituary, please visit the The Courier Journal.

  Read More